In a comprehensive study, Nørgaard et al. assessed GLP-1 RA exposure and subsequent dementia diagnoses among individuals with type 2 diabetes, drawing data from three randomized, double-blind, placebo-controlled trials encompassing over 130,000 participants. The gene discussed is GLP1R; the disease is dementia.